Sunmax Biotechnology Co Ltd (4728) — Free Cash Flow Generation Index
Sunmax Biotechnology Co Ltd (4728) has a Free Cash Flow Generation Index of 0.89x as of September 2025. Free cash flow of NT$143.40 Million represents 1% of operating cash flow (NT$160.84 Million). Read Sunmax Biotechnology Co Ltd debt and liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Sunmax Biotechnology Co Ltd Free Cash Flow Generation Index (2016–2024)
Historical FCF Generation Index trend for Sunmax Biotechnology Co Ltd across 9 annual periods. Explore 4728 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Sunmax Biotechnology Co Ltd (2016–2024)
Year-by-year Free Cash Flow Generation Index for Sunmax Biotechnology Co Ltd. For the full company profile including market capitalisation, see market cap of Sunmax Biotechnology Co Ltd.
| Year | FCG Index | Free Cash Flow (TWD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.91x | NT$360.75 Million | NT$397.37 Million | NT$36.61 Million | ▲ +4.4% |
| 2023 | 0.87x | NT$738.16 Million | NT$848.56 Million | NT$110.39 Million | ▲ +56.3% |
| 2022 | 0.56x | NT$190.94 Million | NT$342.97 Million | NT$152.03 Million | ▲ +1215.2% |
| 2021 | -0.05x | NT$-12.14 Million | NT$243.28 Million | NT$255.43 Million | ▼ -107.5% |
| 2020 | 0.66x | NT$256.88 Million | NT$386.97 Million | NT$130.10 Million | ▼ -29.0% |
| 2019 | 0.94x | NT$270.70 Million | NT$289.51 Million | NT$13.68 Million | ▼ -1.8% |
| 2018 | 0.95x | NT$96.00 Million | NT$100.83 Million | NT$4.72 Million | ▲ +5.6% |
| 2017 | 0.90x | NT$33.44 Million | NT$37.09 Million | NT$3.15 Million | ▼ -29.9% |
| 2016 | 1.29x | NT$21.31 Million | NT$16.58 Million | NT$4.73 Million | — |